Regan Andrew sold CDT

Footnotes

This Form 4 Amendment (the "Amendment") is being filed to amend the Form 4 filed by Dr. Andrew Regan on September 2, 2026 (the "Original Form 4"), to (i) reflect the 1-for-10 reverse stock split of the outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"), of CDT Equity Inc. (the "Issuer") effected on July 20, 2026, (ii) to add Corvus Capital Limited ("Corvus") as a filer due to their status as a 10% owner at the time of the filing of the Original Form 4, and (iii) update certain information regarding Manoira Corporation ("Manoira").; On July 30, 2026, Corvus entered into that certain securities purchase agreement (the "Agreement") with the Issuer and certain other investors of Sarborg Limited, a Cayman Islands Company ("Sarborg"), named therein, pursuant to which, on July 30, 2026, Corvus sold to the Issuer an aggregate of 120 shares of Sarborg (such shares the "Sarborg Shares") and the Issuer issued to Corvus as consideration for the Sarborg Shares pre-funded warrants (the "Pre-Funded Warrants") to purchase up to an aggregate of 543,683 shares of Common Stock, at an exercise price of $0.0001 per share.; The Pre-Funded Warrants include a "cashless" exercise provision, wherein the holder of the Pre-Funded Warrant is entitled to receive a number of shares of Common Stock generally equal to the quotient obtained by dividing the market price minus the exercise price divided by the market price (as further described in the Pre-Funded Warrant). The Pre-Funded Warrants became exercisable on August 28, 2026, following the receipt of stockholder approval for the issuance of the underlying Common Stock, and, on such date, Corvus exercised all of its Pre-Funded Warrants via cashless exercise and received 543,683 shares of Common Stock.; These shares of Common Stock and Pre-Funded Warrants are owned of record by Corvus.; The Pre-Funded Warrants have been exercised in full.; Corvus is the owner of 87.0% of the equity interests of Manoira and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira. Dr. Andrew Regan is the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock and Pre-Funded Warrants held of record by Manoira and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, except to the extent of its or his pecuniary interest therein.